Shockwave Medical, Inc. Common Stock
SWAV
SWAV was delisted on the 30th of May, 2024.
217 hedge funds and large institutions have $4.24B invested in Shockwave Medical, Inc. Common Stock in 2021 Q1 according to their latest regulatory filings, with 34 funds opening new positions, 72 increasing their positions, 79 reducing their positions, and 41 closing their positions.
149% more call options, than puts
Call options by funds: $31.3M | Put options by funds: $12.6M
28% more capital invested
Capital invested by funds: $3.3B → $4.24B (+$938M)
9% less repeat investments, than reductions
Existing positions increased: 72 | Existing positions reduced: 79
4% less funds holding
Funds holding: 227 → 217 (-10)
17% less first-time investments, than exits
New positions opened: 34 | Existing positions closed: 41
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$175M |
| 2 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$104M |
| 3 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$29.3M |
| 4 |
Millennium Management
New York
|
+$29M |
| 5 |
Norges Bank
Oslo,
Norway
|
+$26.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$148M |
| 2 |
Holocene Advisors
New York
|
-$29.9M |
| 3 |
GGHC
Gilder Gagnon Howe & Co
New York
|
-$27.7M |
| 4 |
Morgan Stanley
New York
|
-$24.7M |
| 5 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$24.1M |
SWAV Hedge Fund Activity: Q1 2021 in Review
217 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Shockwave Medical, Inc. Common Stock (SWAV) for Q1 2021, worth a combined $4.24B — up 28% from $3.3B a quarter earlier.
Sellers outnumbered buyers: 41 funds closed out of SWAV and 34 opened new positions — a net loss of 7 holders — while 79 trimmed existing stakes and 72 added.
The largest buyer was T. Rowe Price Associates, adding an estimated $175M. The largest seller was Fidelity Investments, cutting an estimated $148M.
- 217 institutional investors held Shockwave Medical, Inc. Common Stock (SWAV) as of Q1 2021, down from 227 in Q4 2020.
- Funds reported $4.24B of Shockwave Medical, Inc. Common Stock stock for Q1 2021, up 28% quarter-over-quarter.
- 34 funds opened new Shockwave Medical, Inc. Common Stock positions in Q1 2021 and 41 closed out, a net change of -7 holders.
- The largest Shockwave Medical, Inc. Common Stock buyer in Q1 2021 was T. Rowe Price Associates, an estimated $175M added.
- The largest Shockwave Medical, Inc. Common Stock seller in Q1 2021 was Fidelity Investments, an estimated $148M sold.
Based on aggregated 13F filings for Q1 2021.